Page last updated: 2024-08-17

levodopa and ritanserin

levodopa has been researched along with ritanserin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Humphreys, TM; Schmidt, CJ; Sorensen, SM; Taylor, VL1
Abbate, GM; Nieduzak, TR; Schmidt, CJ; Taylor, VL1
Delwaide, PJ; Maertens de Noordhout, A1
De Meirleir, K; Keizer, H; Magnus, L; Meeusen, R; Roeykens, J1

Trials

1 trial(s) available for levodopa and ritanserin

ArticleYear
Endurance performance in humans: the effect of a dopamine precursor or a specific serotonin (5-HT2A/2C) antagonist.
    International journal of sports medicine, 1997, Volume: 18, Issue:8

    Topics: Adult; Analysis of Variance; Blood Chemical Analysis; Carbidopa; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Drug Combinations; Energy Metabolism; Exercise Test; Humans; Levodopa; Male; Physical Endurance; Ritanserin; Serotonin Antagonists; Statistics, Nonparametric

1997

Other Studies

4 other study(ies) available for levodopa and ritanserin

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:2

    Topics: Action Potentials; Amphetamines; Animals; Apomorphine; Carbidopa; Dopamine; Dopamine Antagonists; Fenclonine; Levodopa; Male; Neurons; Piperidines; Rats; Rats, Inbred Strains; Ritanserin

1992
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Anti-Arrhythmia Agents; Brain; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Homovanillic Acid; Levodopa; Male; Nomifensine; Piperidines; Rats; Rats, Inbred Strains; Ritanserin; Serotonin Antagonists; Stereoisomerism; Time Factors

1991
Open pilot trial of ritanserin in parkinsonism.
    Clinical neuropharmacology, 1986, Volume: 9, Issue:5

    Topics: Aged; Antiparkinson Agents; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; Pilot Projects; Piperidines; Ritanserin

1986